Ligand · CDK
CDK · 4-[4-(3,4-dimethyl-2-oxo-2,3-dihydro-thiazol-5-yl)-pyrimidin-2-ylamino]-N-(2-methoxy-ethyl)-benzenesulfonamide
CDK, 4-[4-(3,4-dimethyl-2-oxo-2,3-dihydro-thiazol-5-yl)-pyrimidin-2-ylamino]-N-(2-methoxy-ethyl)-benzenesulfonamide (C18 H21 N5 O4 S2, 435.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding…
- Component
- CDK
- Formula
- C18 H21 N5 O4 S2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
CDK in 2 structures; the first of them:
- 2XMY · Discovery and Characterisation of 2-Anilino-4-(thiazol-5-yl) pyrimidine Transcriptional… · CDK A500 · binds ILE10, VAL18, ALA31, LYS33, VAL64, PHE80, GLU81, PHE82 and 10 more
- 2XMY · Discovery and characterisation of 2-anilino-4-(thiazol-5-yl) pyrimidine transcriptional… · CDK A500 · binds ILE10, VAL18, ALA31, LYS33, VAL64, PHE80, GLU81, PHE82 and 10 more
Residues it binds most
ALA 2, ASP 2, GLN 2, LEU 2, LYS 2, PHE 2, VAL 2, ASN 2, GLU 2, HIS 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.